Ranbaxy wins Baraclude patent case against Bristol-Myers Squibb
The Delhi High Court (HC) has rejected BMS’ plea for an interim injunction to temporarily stop Ranbaxy from producing and selling the drug in India. Justice Sunil Gaur
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.